RIPK3 and myeloid sarcoma: Necroptosis markers, including phosphorylation of RIPK1, RIPK3 and MLKL, were highly detected in pathological samples from MS patients, and there was a pronounced increase of MLKL oligomers in MS pathological samples compared to control [80].